Cargando…
NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is the most prevalent histologic type of lung cancer, associated with a high incidence rate and substantial mortality rate worldwide. Accumulating evidence shows that the aberrant expression of neuromedin U (NMU) contributes to the initiation and progression of cancer. Her...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292091/ https://www.ncbi.nlm.nih.gov/pubmed/34336003 http://dx.doi.org/10.1155/2021/5031479 |